IGI Labs (IG) Misses Q1 EPS by 1c, Q2 Revenue Guidance Falls Short

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to IGI Labs (IG) Misses Q1 EPS by 1c, Q2 Revenue Guidance Falls Short

IGI Laboratories Announces First Quarter 2015 Results

April 28, 2015 4:06 PM EDT

BUENA, N.J., April 28, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced its financial results for the first quarter ended March 31, 2015.

First Quarter 2015 Highlights

Total revenues of $10.7 million in the first quarter of 2015, an increase of 56% over the same quarter in 2014 Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the three months ended March 31, 2015 and 2014 of $8.1 million, and... More